Chemical formula: C₂₀H₂₁F₃N₄O Molecular mass: 390.402 g/mol PubChem compound: 6918248
Flibanserin is a multifunctional serotonin agonist and antagonist used for the treatment of premenopausal women with hypoactive sexual desire disorder. In vitro, flibanserin acts as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors. It also has moderate antagonist activities at the 5-HT2B, 5-HT2C, and dopamine D4 receptors.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G02CX02 | G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CX Other gynecologicals | |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ADDYI Film coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Flibanserin is an active ingredient of these brands:
United States (US)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
